Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: time to get back to sharing information about Bioasis and blood-brain barrier technologies and companies
Yes, in that it's the same XB3 peptide, though each XB3-??? fusion is delivering a different therapeutic that has to show safety and efficacy. Safety and efficacy for intrathecal Herceptin (trastuzumab) has been demonstrated, at least in some case studies, eg.
